R&D tax relief, prepared to withstand HMRC scrutiny

We prepare claims under the merged R&D scheme and ERIS, and we defend them if HMRC asks questions. R&D tax relief is all we do.

Every claim we prepare is built to be read closely.

The technical narrative, the qualifying cost schedules and the return entries, prepared by a regulated chartered practice and signed off by a chartered adviser.

  • Merged scheme

    15%

    What the merged scheme’s 20% expenditure credit is worth per £1 of qualifying spend, net of corporation tax at 25%. It is 16.2% at the 19% rate or where the company is loss-making, and as low as 14.7% where marginal relief applies.

  • ERIS

    26.97%

    What a loss-making, R&D-intensive SME receives in cash per £1 of qualifying spend under ERIS. The payable credit is not taxable.

  • Intensity test

    30%

    The R&D intensity a loss-making SME must reach to claim ERIS, measured against total relevant expenditure, not the R&D alone.

Which scheme applies, and what it is worth

Two schemes are in force for accounting periods beginning on or after 1 April 2024. Which one applies depends on the company, not the date: ERIS for a loss-making SME whose relevant R&D expenditure is at least 30% of its total relevant expenditure, and the merged scheme for every other company.

R&D tax relief rates and eligibility, accounting periods beginning on or after 1 April 2024.
The merged scheme Companies of every size ERIS Loss-making, R&D-intensive SMEs
Rate 20% taxable credit on qualifying expenditure 86% additional deduction and 14.5% payable credit
Worth per £1 15p net1 at the 25% corporation tax main rate; 16.2p at 19%, or for a loss-maker taking it in cash Up to 26.97p, tax free1
Who qualifies Any company with qualifying R&D expenditure A loss-making SME whose relevant R&D expenditure is at least 30% of its total relevant expenditure2

Table notes

  1. Payable credits are capped at £20,000 plus 300% of relevant PAYE and NIC.
  2. The 30% denominator is broadly the trading costs in the accounts for the period, not just the R&D ones.

Correct as at 4 September 2026. Every rate since 2015: R&D tax relief rates by year.

Why companies trust us with their claims

Because we are accountable in ways many R&D agents are not. The mis-selling era left companies facing enquiries their advisers would not defend. Our answer is a regulated, chartered practice — and has been since 2017, under every version of the rules since.

Chartered on both fronts

A member firm of both the Chartered Institute of Taxation (CIOT) and ICAEW, led by a dual-qualified founder, with every claim signed off by a chartered adviser.

Regulated by ICAEW

Including anti-money-laundering supervision, with a published complaints route.

Bound by PCRT

Professional Conduct in Relation to Taxation governs every position we take.

Registered with HMRC

Registered with HMRC as a tax adviser, and named on every claim we prepare.

Enquiry support included

In every engagement as standard. If HMRC opens a compliance check, we handle the response.

We stand behind our work

We prepare the right claim, defensibly. Read about our regulation and standards.

Who we work with

Companies whose business is their R&D. Sector by sector, claims trip up in different places — each card names the complication we solve most often.

How it works

Four steps, one chartered adviser throughout. Your fee is agreed in writing before work starts, with no hidden costs.

See the full process
  1. Scoping call

    A conversation about your work and your numbers. If we do not think you qualify, we say so.

  2. Technical and financial workstreams

    We interview your competent professionals, set the project boundaries and build the qualifying cost schedules.

  3. Report and return

    The technical report, the Additional Information Form and the return entries, prepared and filed by us as HMRC-registered agents.

  4. Submission and aftercare

    We submit, track progress with HMRC, and enquiry support is included as standard.

  • Contingent fee, agreed before work starts
  • Signed off by a chartered adviser
  • Enquiry support included as standard

Our clients’ words

Hear from the R&D-performing companies we act for. More client feedback is on our testimonials page.

“We’ve worked with LimestoneGrey for several years and their professionalism, speed and clear approach make them a pleasure to work with. They quickly understand the complexities of our R&D and ensure the claims process is straightforward, fair and accurate.”

Sandy

Jellagen Limited

“Working with LimestoneGrey has been a genuinely positive experience. Their communication is clear and proactive and they are always on hand to answer queries and provide reassurance throughout the process. We have complete trust in their expertise and feel confident that our claims are being handled professionally.”

Dr Varghese

Laennec AI Limited

“We have been very happy with the service provided by LimestoneGrey. In particular, their attention to detail has been exceptional, making the entire process smooth and reassuring for us.”

Marcus

Neurabotics Limited

Recognition

Finalist, One Nucleus Awards 2026: Most Innovative Professional Services Company

Finalist, Finance Awards Wales 2026: Independent Practice of the Year

Business Wales Accelerated Growth Programme Gold Partner

Memberships and associations

We are members of, and work alongside, the innovation and life-sciences networks our clients operate in, across the UK.

Latest thinking

Technical analysis and firm news from the team, written by the advisers who prepare the claims.

View all insights

Talk it through with a chartered adviser

A first conversation costs nothing and commits you to nothing. You will speak to a qualified adviser, not a salesperson.

Based
Cardiff, serving the UK
Request a scoping call